March 29, 2024 04:57 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi has mastered art of manipulating democracy, hurting Constitution: Mallikarjun Kharge | Mafia-turned-politician Mukhtar Ansari dies of cardiac arrest at 63 | NIA arrests key conspirator in Bengaluru cafe blast case | Actor Govinda returns to politics after 14 years of 'vanvas', joins Eknath Shinde camp | 'To browbeat and bully others is vintage Congress culture': PM posts after 600 lawyers write to CJI

Genpact completes acquisition of Pharmalink Consulting

India Blooms News Service | | 30 May 2014, 09:43 pm
New York, May 30 (IBNS): Genpact Limited, a global leader in transforming and running business processes and operations, has closed its previously announced acquisition of Pharmalink Consulting recently.

Now part of Genpact’s growing life sciences vertical, the new business is named Genpact Pharmalink Global Regulatory Affairs.

Genpact Pharmalink Global Regulatory Affairs combines Pharmalink’s specialized domain expertise in consulting, project support and outsourced regulatory affairs services with Genpact’s global delivery, BPO, technology and analytics offerings for the life sciences market.

Genpact’s expanded capabilities now support core life sciences R&D functions such as regulatory strategy, filings, complex compliance services, patient safety and management of post-licensing activities.

“Genpact is thrilled to add this extremely talented group of life sciences experts to our growing operations,” said Balkrishan Kalra, senior vice president and business leader, Life Sciences, Genpact. 

“We are confident that Genpact Pharmalink Global Regulatory Affairs will transform the way life sciences companies address the ongoing and complex challenges in the area of regulatory affairs," Kalra said.

“With significant cultural synergies that have been evident from the outset, our team across the US, UK, India, Ireland and Puerto Rico is excited to be officially part of Genpact,” said Kevin Webb, chief operating officer, Genpact Pharmalink Global Regulatory Affairs. 

Webb said: “We are already developing a next generation offering to meet growing needs within a rapidly-changing market.”

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.